Let the games begin.
The US Food and Drug Administration (FDA) has announced the clearance of the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people aged 6 years or older with type 1 diabetes. Now it’s time for the games to begin.
Here’s our take on how this might play out.
1. Insulet has the least to worry about here – the Omnipod 5 will continue to gain new users.
2. Medtronic shouldn’t be overly concerned as the 780 now available here in the US has received positive reviews and the company will do . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.